Page 22 - JCTR-10-6

332 Barreto et al. | Journal of Clinical and Translational Research 2024; 10(6): 325-333
#2768/22, #3515/23, and #3462/23). INFABIC is co-funded by [5] Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B,
FAPESP (#2014/50938-8) and CNPq (#465699/2014-6). Taphoorn MJ, et al. Radiotherapy Plus Concomitant and
Adjuvant Temozolomide for Glioblastoma. N Engl J
Conflicts of Interest Med 2005;352:987-96.
The authors declare no conflicts of interest. doi: 10.1056/NEJMoa043330
[6] Rapôso C, Vitorino-Araujo JL, Barreto N. Molecular
Ethics Approval and Consent to Participate Markers of Gliomas to Predict Treatment and Prognosis:

All methods and experiments were performed strictly Current State and Future Directions. In: Brain Tumor
following the guidelines of the Research Ethics Committee Center of Excellence, Wake Forest Baptist Medical
from the University of Campinas (UNICAMP - Campinas, São Center Comprehensive Cancer Center, Winston Salem,
Paulo, Brazil): CAAE: 15215219.5.0000.5404, and from the NC, USA, Debinski W, editors. Gliomas. Australia:
Central Hospital of Santa Casa (São Paulo, Brazil): CAAE: Exon Publications; 2021. p. 171-86.
15215219.5.3001.5479. Animal experimentation was carried doi: 10.36255/exonpublications.gliomas.2021.chapter10
out following the Ethical Principles on Animal Research, [7] Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y,
adopted by the Brazilian College of Animal Experimentation Wolinsky Y, et al. CBTRUS Statistical Report: Primary
(Colégio Brasileiro de Experimentação Animal, COBEA), Brain and Central Nervous System Tumors Diagnosed
and approved by the Ethics Committee on the Use of Animals in the United States in 2006-2010. Neuro Oncol
(CEUA/UNICAMP; 6200-1/2023). All authors provided 2013;15:ii1-56.
consent for publication. doi: 10.1093/neuonc/not151
Consent for Publication [8] Tan AC, Ashley DM, López GY, Malinzak M,
Friedman HS, Khasraw M. Management of Glioblastoma:
Tissue samples were obtained after informed patient State of the Art and Future Directions. CA Cancer J Clin
consent (Informed Consent Form [TCLE]). By signing the 2020;70:299-312.
TCLE, patients agreed to disclose images and data for research doi: 10.3322/caac.21613
purposes. [9] Barretina J, Caponigro G, Stransky N, Venkatesan K,
Availability of Data Margolin AA, Kim S, et al. The Cancer Cell Line
Encyclopedia Enables Predictive Modelling of Anticancer
Data are available from the corresponding author upon Drug Sensitivity. Nature 2012;483(7391):603-7.
reasonable request. doi: 10.1038/nature11003
References [10] Huo KG, D’Arcangelo E, Tsao MS. Patient-derived Cell
Line, Xenograft and Organoid Models in Lung Cancer
[1] Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Therapy. Transl Lung Cancer Res 2020;9:2214-32.
Kruchko C, et al. CBTRUS Statistical Report: Primary doi: 10.21037/tlcr-20-154
Brain and Other Central Nervous System Tumors [11] Machado CM, Schenka A, Vassallo J, Tamashiro WM,
Diagnosed in the United States in 2012-2016. Neuro Gonçalves EM, Genari SC, et al. Morphological
Oncol 2019;21:v1-100. Characterization of a Human Glioma Cell Line. Cancer
doi: 10.1093/neuonc/noz150 Cell Int 2005;5:13.
[2] Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, doi: 10.1186/1475-2867-5-13
Figarella-Branger D, et al. The 2021 WHO Classification [12] Grippo MC, Penteado PF, Carelli EF, Cruz-Höfling MA,
of Tumors of the Central Nervous System: A summary. Verinaud L. Establishment and Partial Characterization
Neuro Oncol 2021;23:1231-51. of a Continuous Human Malignant Glioma Cell Line:
doi: 10.1093/neuonc/noab106 NG97. Cell Mol Neurobiol 2001;21:421-8.
[3] Barreto Dos Santos N, Bonfanti AP, da Rocha-E-Silva TA, doi: 10.1023/a:1012662423863
Da Silva PI Jr., Da Cruz-Höfling MA, Verinaud L, et al. [13] Barreto N, Caballero M, Bonfanti AP, de Mato FC,
Venom of the Phoneutria nigriventer Spider Alters the Munhoz J, da Rocha-E-Silva TA, et al. Spider Venom
CELL Cycle, Viability, and Migration of Cancer Cells. Components Decrease Glioblastoma Cell Migration and
J Cell Physiol 2019;234:1398-415. Invasion through RhoA-ROCK and Na+/K+-ATPase
doi: 10.1002/jcp.26935 β2: Potential Molecular Entities to Treat Invasive Brain
[4] Higginbottom SL, Tomaskovic-Crook E, Crook JM. Cancer. Cancer Cell Int 2020;20:576.
Considerations for Modelling Diffuse High- doi: 10.1186/s12935-020-01643-8
grade Gliomas and Developing Clinically Relevant [14] Bonfanti AP, Barreto N, Munhoz J, Caballero M,
Therapies. Cancer Metastasis Rev 2023;42:507-41. Cordeiro G, Rocha-E-Silva T, et al. Spider Venom
doi: 10.1007/s10555-023-10100-7 Administration Impairs Glioblastoma Growth and

DOI: http://doi.org/10.36922/jctr.24.00028